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In a world of changing disease burdens, poor quality care and constrained health budgets, finding effective
approaches to developing and implementing evidence-based health services is crucial. Much has been published
on developing service tools and protocols, operational research and getting policy into practice but these are often
undertaken in isolation from one another. This paper, based on 25 years of experience in a range of low and middle
income contexts as well as wider literature, presents a systematic approach to connecting these activities in an
embedded development and research approach. This approach can circumvent common problems such as lack
of local ownership of new programmes, unrealistic resource requirements and poor implementation.
We lay out a ten-step process, which is based on long-term partnerships and working within local systems and
constraints and may be tailored to the context and needs. Service development and operational research is best
prioritised, designed, conducted and replicated when it is embedded within ministry of health and national
programmes. Care packages should from the outset be designed for scale-up, which is why the piloting stage is so
crucial. In this way, the resulting package of care will be feasible within the context and will address local priorities.
Researchers must be entrepreneurial and responsive to windows of funding for scale-up, working in real-world contexts
where funding and decisions do not wait for evidence, so evidence generation has to be pragmatic to meet and ensure
best use of the policy and financing cycles. The research should generate tested and easily usable tools, training materials
and processes for use in scale-up. Development of the package should work within and strengthen the health system
and other service delivery strategies to ensure that unintended negative consequences are minimised and that the
strengthened systems support quality care and effective scale up of the package.
While embedded development and research is promoted in theory, it is not yet practiced at scale by many
initiatives, leading to wasted resources and un-sustained programmes. This guide presents a systematic and
practical guide to support more effective engagements in future, both in developing interventions and supporting
evidence-based scale-up.
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In a world of growing and changing disease burdens and
constrained health budgets, finding effective approaches
to developing and implementing evidence-based health
services is crucial, and underpins the Sustainable Health
Goal target of Universal Health Coverage [1]. Much has
been published on evidence review and developing
guidelines [2],operational and implementation research
[3], knowledge brokering [4–6], getting policy into prac-
tice [7–9], and on embedded research [10] but these are
often described and undertaken in isolation from one
another. Moreover, much of the literature is based on
higher income country experiences. This paper, which is
based on 25 years of experience in developing and
strengthening service delivery for communicable and
non-communicable diseases in low and middle income
countries, presents a systematic approach to connecting
these activities in an embedded development and re-
search approach.
Embedded development and research is here used to in-
dicate two important but distinct aspects: first, that all
stages of the process are co-produced by researchers (local
and international) and local programme managers, work-
ing in close partnership but bringing different skills, in-
sights and connections; and secondly, that the
intervention and associated research are closely tailored to
local needs and resources (in other words, are themselves
well embedded as part of the development process). This
can circumvent common problems such as lack of local
ownership of new programmes, unrealistic resource re-
quirements and poor implementation [11]. This approach
can be broken down into ten steps, grouped into four
stages, which are described below (with an example from
one area of work given in Box 1). While the steps may be
familiar, they are rarely undertaken systematically and se-
quentially. We believe that following this step-wise ap-
proach greatly improves the chance of health services
being of high quality, universal, effective and sustained,
even in challenging low and middle income contexts.
Ten steps
Designing and developing the service delivery package
Research into a weak, poorly contextualised or unsus-
tainable intervention is a waste of precious time and re-
sources, which is why our process begins with a careful
design and development stage. This typically comprises
four steps: (1) assess the problem; (2) identify options
for addressing them; (3) carry out additional exploratory
research as required; and (4) develop locally adapted
tools and service guidelines.
1. Assess the problem
The intervention and its associated guidelines and tools
should be designed according to the best evidenceavailable and in line with the local context. The process
therefore starts with a review, in collaboration with local
programme managers and policy-makers in Ministries of
Health, of existing literature on the problem’s distribution
and underlying causes, as well as the experiences of earlier
programmes there and elsewhere (barriers to service de-
livery and user access, what has been learned about ad-
dressing them, resource requirements etc.) [12]. Where
researchers, local and international, work in a long-term
partnership with programmes and ministries, they already
know the context and assessment can be tightly focussed
on the new potential intervention – involving, for ex-
ample, rapid data collection with a checklist at a few facil-
ities to identify bottlenecks and opportunities.
2. Identify options for addressing the problem
This step involves a review of the best technical interven-
tions for the disease or condition, often based on system-
atic reviews (for example, [1, 13, 14], original research
papers, programme reports and guidelines from the
World Health Organisation or other international devel-
opment organisations, as relevant. Evidence from these
can be presented in an adaptation guide (for example,
[15]), which includes the options and evidence relevant
for the specific country setting.
3. Carry out additional exploratory research
Where relevant information is lacking, such as on local
health behaviours, exploratory research should be car-
ried out to inform and refine the intervention. For ex-
ample, there may be a need to better understand the
beliefs and practices of clients and service providers re-
lating to the disease or condition (for example, [2, 3, 16].
Gathering this information early in the process will help
to ensure that the guides, tools and case studies used in
training are adapted to take into account prevalent be-
liefs, practices and systems [17, 18].
4. Develop a package of guidelines and tools adapted to
the local context
Based on the previous steps, the research team can now
develop a package that incorporates current knowledge
on effective interventions and that includes practical
guidelines and tools [19]. It should designed to be effect-
ive and feasible within the country health service context
– i.e. evidence-based and high-quality, but also taking
into account the way that health facility and district
health systems are configured, as well as the resources
which are available (such as staff time, funding and
equipment). The package may be used as a vehicle to
introduce research-informed approaches – for example
new diagnostic procedures, drug regimens, changes to
organisation or processes of care, treatment support and
training methods – into practice at scale.
Box 1: Case study from Punjab, Pakistan
The establishment of a non-communicable disease (NCD) control Pakistan provides an example of how the ten-step process worked in a real life
situation. It was based on collaboration between the Department of Health, Punjab, and an international research consortium, COMDIS-HSD,
which included public health practitioner-researchers based at the University of Leeds and a non-governmental association, the Association for
Social Development, based in Islamabad. The partnership has extended over 25 years, researching and developing all components of the TB
programme (implemented nationally) and other chronic diseases, allowing for the development of mutually trusting relationships.
1. The scale of the problem was recognised in 2011, when the World Health Organisation (WHO) assisted the health department In
Punjab to estimate the disease burden and identify wide variation in NCD care practices.
2. The Director General for Health Services Punjab formed a Technical Working Group, including COMDIS, and selected conditions
for priority attention. Researchers reviewed the available WHO and other NCD literature.
3. Exploratory studies were conducted by COMDIS on these priority conditions, i.e. diabetes-hypertension and asthma-COPD. Services
were found to be ad hoc clinical care only; and the focus was on how to improve access, deliver care, supervision and supplies within
the district health system.
4. The package was drafted by COMDIS researchers and development team with others within the TWG. The draft products were
developed according to the context, and included a case management desk guide, a counselling illustrated ‘flipchart’, record cards,
training modules with case studies and communication skills role plays.
5. COMDIS pre-tested the guides and tools with a group of primary care doctors and other target users.
6. We jointly pilot-evaluated the intervention package at two health facilities, selected by the department of health NCD programme.
This was a key opportunity to refine details of the desk guide, and the service delivery details outline in the package (i.e., the what,
where and how of each step in the care process).
7. Trials of effectiveness were conducted; with three embedded trials i.e. diabetes-hypertension care at public rural and private urban
facilities and asthma-COPD care at public facilities. All were implemented with department of health staff and resources. This was
as planned and with good results, except for diabetes (insufficient time was given prior to assessing outcomes).
8. Incremental cost effectiveness analysis was also designed and conducted for diabetes-hypertension and the asthma-COPD, giving
the costs of replication of the service interventions.
9. Process evaluation of the care delivery of diabetes-hypertension (at public and private facilities was) and asthma-COPD interventions
were designed and conducted, assessing the loss to follow-up at each stage of the care pathway from screening onwards – and refining
accordingly.
10. Scale-up was by the Department of Health, setting up and funding NCD programme with technical support by UNICEF in strategic
planning and by; COMDIS in the preparation of public funding proposal, briefing documents and presentations for the programme
focal person. Thereafter provincial scale-up was by the programme alone.
There were many challenges, such as ensuring district health office supply of record cards and essential drugs, as well as coping with changes in
the senior department of health managers. However, the success of the ten-step process is indicated by the fact that the integrated NCD care
interventions have now been scaled up during 2017–8, through public funding, to facilities within all 36 districts of Punjab, a province with a
population of more than 100 million.
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within, and strengthen, the existing health system. This in-
cludes necessary supportive health system strategies, such
as managing medications and other supplies, assuring qual-
ity of laboratory testing, staff training, referral pathways,
and performance monitoring and supervision, all of which
should be included in the guides and tools.
The national programme may already have a guideline
providing broad policy, drug regimens, roles and respon-
sibilities. These are necessary, but not generallysufficient. The package of care to be developed often
needs to include the following:
 User-friendly operational guides to meet the needs
of managers (for example, district implementation
planning, supervision, performance management
and community intervention guides)
 Case management desk guides (concise, practical
and role-specific handbooks) for doctors, nurses
and paramedics to use during patient consultations.
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identification, diagnosis, education and follow-up.
The guide and tools may be used by public,
non-governmental organisation and private
providers or educators.
 For community health workers, simple and concise
case management and health education tools, often
called “job aids”
 Tools including treatment cards, registers, patient
education flipcharts and leaflets and training
modules for health workers.
Adaptation and development of the package can be
organised around three steps [20]:
(1) Initially the package is “pre-edited” by one or more
health professionals experienced in the country,
specific disease and service delivery context.
(2) Next a technical working group is formed.
This should consist of around 6 people, familiar with
the content and setting, who can work around a table.
Representation should include relevant programme
managers, care providers, technical partners (, such as
theWorld Health Organisation, UNICEF, other
non-governmental partners), and clinical and interven-
tion development experts. They should understand the
public health approach requiring standardisation and
be able to simplify procedures so that these will be
feasible when scaled up. They should not assume, for
example, that many lab tests and treatments used in
tertiary hospitals will be available in primary care.
They should also ensure that local terminology,
suitable for health managers and facility staff, is used.
They should meet weekly or attend a 2–3 day
workshop and should review and edit the
pre-edited materials section by section.
Comments and revisions can also be collected
prior to reduce the time of the workshop.
During the workshop, particular issues should be
discussed, and changes agreed, while the facilitator
notes down what requires further editing.
Good communication within the group is essential.
(3) Lastly a steering committee including senior
decision-makers reviews and endorses the use
of the materials.
Typical types of adaptation may include:
 Adapting operational strategies to deliver each care
or intervention task;
 Editing treatment regimens according to national
guidelines;
 Adding or amending treatment record cards and
registers; Developing health education, lifestyle and adherence
messages for the specific disease, and adherence
support strategies e.g. by family members,
volunteers or by mobile phone, with follow-up care
in the health centre.
It is vital that interventions are designed from the start
to be feasible, sustainable and widely replicable.
Pre-test and pilot the package
This stage is critical in road-testing the package in real
contexts, ironing out problems and carrying out a sec-
ond wave of adaptations as needed to make it feasible
and acceptable. If a rapid decision is needed on whether
to scale up, this stage, with its accompanying small-scale
research, can be sufficient to inform robust implementa-
tion and scale-up.
5. Pre-test the guides and tools
Pre-testing commonly involves reviewing the contents of
drafted materials, with a group of selected care providers
and programme staff, getting their feedback on the ap-
propriateness of the content (i.e. adequacy, correctness,
acceptability etc.) and revising as necessary. The purpose
of pre-testing is to ensure tools do what they are sup-
posed to do e.g. a picture conveys the intended message;
a role play exercise teaches the individual the intended
skill; a register records the intended information..
Pre-testing should be done before piloting with real pa-
tients or in a community intervention [20, 21].
6. Pilot
Piloting, also called feasibility assessment, involves trying
the package out at small scale to assess feasibility and
acceptability, and if necessary making revisions. It is im-
portant to try out the new intervention under routine
conditions to test the feasibility of the delivery strategy.
Piloting should be in an accessible district, selecting a
few health facilities or villages. A training course is run
with relevant health workers. The facilitators take turns
running the sessions and annotating the guides and
module content to improve clarity. The intervention, in-
cluding the supervision and monitoring, is implemented
for some months in the chosen pilot sites. During the
pilot, health workers record (using the proposed treat-
ment cards and registers and community outreach re-
cords as relevant) data on the care process. The staff
adherence to the care protocols is assessed through re-
view of patient records, supported (if possible) by obser-
vation and interviewing, whereas the client adherence to
follow-up visits is assessed from ‘drop-outs’ through
each stage of the process [22].
The package may also be tested using one or more
qualitative methods, such as interviews, group
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Studies assess the feasibility and acceptability of the
intervention package from the perspective of the service
providers and users. The intervention and study can
then be improved based on the findings of the pilot [20].
Unfortunately, “piloting” has obtained a bad reputation
because commonly projects do not get beyond the pilot
stage, often because the intervention has not been de-
signed to be sustainable and replicable. For example, a
well-funded pilot may achieve good results which are
not sustained under normal programme funding; or a
pilot supported by project team time achieves good re-
sults, but scale-up fails when similar support is not avail-
able nationwide. (Such pilots should more accurately be
termed demonstration sites.) The carefully designed and
implemented pilot is an opportunity to refine the pack-
age under routine conditions, with the procedures,
guides and tools corresponding with the human, mater-
ial and financial resources that will realistically be avail-
able during scale-up.
Implement and evaluate the intervention
Implementation and financing of the package should be
led by the national programme or Ministry to ensure
that it is technically and financially sustainable. If there
is interest, time and funds, larger scale trials, economic
evaluations and process evaluation can accompany the
implementation, as described below.
7. Evaluate effectiveness using an embedded trial
In embedded research we often evaluate as part of
phased programme implementation. It is best for pro-
grammes not to attempt to implement everywhere at
once. This may seem obvious, but often programmes in-
struct all sites nationwide to implement together before
they are ready. This results in poor implementation and
poor outcomes. Effective implementation requires much
care to ensure local procedures are ready. The interven-
tion can then be implemented site by site, systematically
scaling up until all sites are covered. Phased implemen-
tation provides an opportunity to develop a randomised
controlled trial. Trial sites are randomly allocated to
early-implementation ‘intervention’ sites, and outcomes
compared with those from pre-implementation ‘control’
sites, to estimate the effectiveness of the package relative
to the existing service [4, 23–25]. External research sup-
port is generally needed to plan and execute a rando-
mised controlled trial [26].
In randomised controlled trials and other controlled
evaluations it is important to implement standardised
case identification and recording on treatment cards and
registers in both the intervention and control sites, also
ensuring that all equipment, lab tests and drugs needed
are available for all patients. The trial can be of the carepackage as a whole, with the control sites continuing
with ‘usual’ (existing) care [21, 27–29], or of a compo-
nent of the package such as lifestyle behaviour change
[30, 31]. In either case, the elements to be trialled are
omitted from the control sites’ guides and tools.
8. Evaluate costs and cost-effectiveness
Costing studies are often conducted alongside evaluation
of effectiveness. At a minimum, assessment is of the in-
cremental cost to the health service to add the service.
This form of economic evaluation estimates the likely
costs to the provider to replicate the service, should it be
found effective. It is also useful to carry out an incre-
mental cost effectiveness analysis, to estimate the incre-
mental cost per successful treatment (for example, the
incremental cost per child using a bednet, per child vac-
cinated or per successfully-treated TB patient) [32, 33].
It is often important to also estimate changes in costs to
patients that result from new strategies (e.g. switching
from hospital-based to community-based care for
drug-resistant tuberculosis) to identify when health ser-
vice costs are transferred to patients. The cost and
cost-effectiveness studies are useful to estimate the cost
of scaling up and what implications this will have for na-
tional or local health budgets, and can be used to lever-
age additional programme funding.
9. Evaluate the implementation of various parts of the package
Process evaluations systematically explore what happens
within the package, rather than merely looking at the
package as a whole. Process evaluation studies may be
conducted to understand the “why” of results, for ex-
ample why the package was (or was not) more effective
than usual care [34]. Sites, clinicians and clients are ob-
served and interviewed to find out which parts of the
guides and tools were used as intended, and which parts
were not (‘fidelity’ to the package), the reasons behind
this, and how they can be addressed [34]. The study may
assess interventions in terms of ‘how’ the patient, family,
and community factors, such as access to and quality of
the community intervention or health service, and direct
and opportunity costs influence patients’ ability to at-
tend, be diagnosed, treated and adhere to follow-up ap-
pointments [5, 35]. As with the pilot qualitative study,
this may comprise semi-structured interviews with vari-
ous categories of patients and carers, and focus groups
with family, community members, providers and man-
agers, as appropriate.
Support policy and practice change
In the embedded research and development approach, scal-
ability of the package is addressed from the start, which en-
ables support to scale up and wider dissemination.
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Through all stages, the approach is to develop services
that align with national policies and are adapted to be
feasible and effective in the local context. Implementa-
tion and financing is led by the programme rather than
researchers. There is collaboration between researchers
and the programme managers and service providers at
different levels of the health system (as relevant, based
on the nature of the intervention) to develop, adapt,
pilot and roll out the package. In this final stage, all par-
ties discuss the research findings, informing further
changes to guides and services. National scale-up of the
package by the national programme should initially be
with support from local and international researchers.
Researchers need to actively look for any policy oppor-
tunities that can embed the interventions to promote
wider dissemination at the system level.
In relation to planning and financing, joint actions at
this stage include:
 Obtaining decision maker approval, which may
require drafting briefing documents and preparing
presentations
 Integrating the intervention in programme plans,
which may require drafting or editing documents,
facilitating discussions, and making presentations
 Mobilising resources from public and donor sources,
which may require drafting of proposal(s),
responding to queries, and revising proposals in
response to comments
Implementation activities commonly include:
 Printing the finalised materials for use in pre- and
in-service courses and on-going service delivery
 Rolling out training, including teaching the skills to
use these materials through role-play exercises
 Ensuring drugs, cards, registers and laboratory
materials are available in time so that health workers
can immediately put into practice what they learnt
in training
 Follow-up after training, including supervisory visits
to each participant to observe and give encouragement,
both as they start to use the guide and tools, and
systematic routine monitoring of performance [36].
The learning and the products are disseminated both in
the country and internationally (though the usual chan-
nels such as meetings, presentations, project briefs and
peer-reviewed publications). The intervention and package
of care can be edited to become a non-country-specific
‘generic’ version, available for adaptation in other coun-
tries, following the stages of service development and re-
search outlined above [20].Conclusions
We describe in this article a set of ten steps which have
been found to work well in a range of low and
middle-income countries in Africa and Asia over a
20-year period in delivering scaled-up, evidence-based
health service programmes at different levels of the
health system which bring important health benefits for
communities. This is not a rigid process and should be
tailored to the context and needs. However, it is import-
ant to understand and respect the underlying approach,
which is based on long-term partnerships and working
within local systems and constraints. Service develop-
ment and operational research are best prioritised, de-
signed, conducted and replicated when embedded within
Ministry of Health and national programmes. In this
way, packages of care will address local needs and be
feasible there. There is no benefit to testing an infeasible
package, yet commonly, researchers test ‘ideal’ but im-
practical strategies, then seek to ‘market’ their results to
policy-makers. Care packages should from the outset be
designed for scale-up, which is why the development
and piloting stages are so crucial.
Development should be accompanied by research, which
informs it in an iterative way, with scale of research tailored
to the level of importance of the questions and the avail-
able resources and time. Researchers must be responsive to
windows of funding for scale-up (domestic and inter-
national, such as global funds for AIDS, TB, malaria),
working in real-world contexts where funding and deci-
sions do not wait for evidence, so evidence generation has
to be pragmatic and timely to meet and ensure best use of
the policy and financing cycles. This requires policy entre-
preneurial skillsets which may not have been in the trad-
itional researcher toolbox, as well, of course, as the ability
to foster and deliver robust research and work with part-
ners from the health provider level up to Ministry of
Health, and including public and private sectors. Some of
these organisations present difficult environments for
evidence-based programming, with limited time and incen-
tives [37]; however, skilled identification of champions and
windows of opportunity, as well as sheer perseverance, can
allow for success. The development and research go to-
gether, in order to generate tested, practical and easily us-
able tools and training materials and processes for use in
scale-up. In low-middle income settings in particular,
where resources are constrained and systems at risk of
fragmentation, development of the package should ensure
that it works within and helps strengthen the health sys-
tem, taking into account other service delivery priorities, to
minimise wider unintended adverse effects.Abbreviations
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